Inhaled aviptadil for the possible treatment of COVID-19 in patients at high risk for ARDS: study protocol for a randomized, placebo-controlled, and multicenter trial.

Saved in:
Bibliographic Details
Title: Inhaled aviptadil for the possible treatment of COVID-19 in patients at high risk for ARDS: study protocol for a randomized, placebo-controlled, and multicenter trial.
Authors: Boesing, Maria1,2 (AUTHOR) maria.boesing@ksbl.ch, Abig, Kristin1 (AUTHOR), Brändle, Michael3 (AUTHOR), Brutsche, Martin3 (AUTHOR), Burri, Emanuel1 (AUTHOR), Frye, Björn C.4 (AUTHOR), Giezendanner, Stéphanie1 (AUTHOR), Grutters, Jan C.5,6 (AUTHOR), Haas, Philippe7 (AUTHOR), Heisler, Justian1,2 (AUTHOR), Jaun, Fabienne1 (AUTHOR), Leuppi-Taegtmeyer, Anne B.1,8 (AUTHOR), Lüthi-Corridori, Giorgia1,2 (AUTHOR), Müller-Quernheim, Joachim4 (AUTHOR), Nüesch, Reto9 (AUTHOR), Pohl, Wolfgang10 (AUTHOR), Rassouli, Frank3 (AUTHOR), Leuppi, Jörg D.1,2 (AUTHOR)
Source: Trials. 9/20/2022, Vol. 23 Issue 1, p1-13. 13p. 1 Black and White Photograph, 1 Chart.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17456215
DOI:10.1186/s13063-022-06723-w